Although there is no exact consensus regarding the changes of MMP/TIMP activities and levels measured in blood or CSF of AD patients, MMPs are supposed to be indicative of tissue remodeling, progression of MCI to AD, and prognosis of patients suffering from AD. Here, TIMP1 is linked to Alzheimer disease.